GLP-1 microdosing — taking semaglutide or tirzepatide at doses below the standard maintenance levels — is one of the loudest trends in online weight loss care in 2026. The pitch is seductive: milder nausea, a smaller bill, and just enough appetite control. Here is the part the ads skip: no major randomized trial has ever tested microdosing for weight loss. The famous results all came from full doses — about 14.9% average weight loss at 2.4mg of semaglutide over 68 weeks in STEP 1, and up to ~20.9% at high-dose tirzepatide over 72 weeks in SURMOUNT-1.
So this page does two jobs. First, it ranks the five telehealth providers where a low-dose plan is actually practical — led by Noom Med, the only one selling an explicit Microdose tier, at $79 for the first month. Second, it draws a hard line between what clinicians can reasonably do off-label and what marketing departments claim. All prices were checked in July 2026, and every score is an editorial rating built from documented research, not first-hand drug testing.
1. Noom Med — The Only Named Microdose Program
Every other company on this list makes you improvise a low-dose plan out of flat pricing. Noom Med is the exception: its Microdose GLP-1Rx plan is a distinct product with its own pricing page, pairing low-dose compounded semaglutide with clinician oversight and the full Noom behavior-change app. In December 2025 it went further, launching Proactive Health GLP-1Rx, which bundles microdosing with 17-marker at-home biomarker testing.
Pricing Structure
The Microdose tier costs $79 for the first 4-week supply, then $199/month billed quarterly per Noom’s pricing hub — roughly $597 per 12 weeks after the promo. Oddly, Noom’s own product page listed the same plan at $179/month (billed $537 per 12 weeks) the same week in July 2026, an inconsistency worth screenshotting before you buy. Standard-dose compounded semaglutide runs $129 the first month, then $249/month quarterly, and the Proactive Health plan bills $149 every 4 weeks with a 15-week first term. Plans are FSA/HSA eligible; compounded plans are not offered in Alabama, Louisiana, or Mississippi.
Pros & Cons
Pros: Noom says its compounded medication comes from an FDA-regulated 503B outsourcing facility — the stricter compounding standard. The company has a BBB A+ rating, accredited since 2021, and has operated since 2008, ancient by this industry’s standards. Its Taper-Off Guarantee (free Noom for a year or medication discounts if you regain within 18 months after the 12-month protocol) is unique.
Cons: Noom’s microdose weight claims — up to 17 pounds in 60 days, average 13 — are company marketing with no peer-reviewed microdose trial behind them. Quarterly lump-sum billing surprises people, the $79 headline nearly triples after month one, and compounded semaglutide is not FDA-approved, as Noom’s own disclaimer states.
2. bmiMD — The Budget Microdose Line Nobody Advertises
Here is a quiet fact from our research: bmiMD sells dedicated microdose versions of both compounded semaglutide and compounded tirzepatide as their own product lines — it just does not shout about them the way Noom does. Combined with the lowest flat pricing in this ranking, that makes the New York telehealth company (operating since late 2022) the strongest budget path to low-dose therapy.
Pricing Structure
Compounded semaglutide costs $99/month on a 12-month plan (billed $1,188 at once), $109 on 6 months, $119 on 3 months, or $129 month-to-month — and the price is identical at every dose, microdose included. Tirzepatide runs $139–$159/month by plan length, with an $89.50 first-month promo for new members. The price bundles the telehealth visit, medication, unlimited provider messaging, and free shipping on subscriptions; HSA/FSA and buy-now-pay-later are accepted.
Pros & Cons
Pros: Your card is authorized but not charged until a provider approves you — ineligible applicants pay nothing. bmiMD publishes quality-testing claims (potency within ±10% verified every 3–6 months, USP 797 sterility, USP 85 endotoxin testing by FDA- and DEA-registered labs, per the company). Trustpilot sits around 4/5 across roughly 800+ reviews.
Cons: The $99 rate demands $1,188 upfront. All sales are final once the pharmacy processes an order, and cancelling between intake approval and pharmacy processing costs a $50 fee. BBB rates the company C+ with 38 complaints, its compounding pharmacies are unnamed with no 503A/503B disclosure, and there is no brand-name option at all.
3. TrimRx — Flat Pricing Built for Staying Low
San Diego-based TrimRx (founded June 2024) has no microdose tier — but its whole pricing model happens to suit one. Because every plan is one flat, all-inclusive price with dose adjustments included, a clinician can start you at 0.25mg or 0.5mg and simply keep you there, and your bill never knows the difference.
Pricing Structure
Compounded semaglutide starts at $199/month with an annual commitment; standard month-to-month runs about $349. Compounded tirzepatide is $349/month at every dose from 2.5mg to 15mg ($449 without the promo rate). The price covers provider consultations, a 4–5 week medication supply, syringes, alcohol pads, a sharps container, and cold-chain shipping — and $0 is charged until a prescription is approved. Cash-pay only; HSA/FSA accepted.
Pros & Cons
Pros: No membership or platform fees, a genuine month-to-month option if you refuse contracts, and BBB accreditation since June 2025.
Cons: That BBB profile is currently listed as under review with no letter rating shown. Trustpilot averages a polarized ~3.3/5 across ~727 reviews, with complaints clustered on multi-month upfront billing and cancellation friction — and prepaid plans reportedly give no refunds for unused months. TrimRx does not name its compounding pharmacies, and its own blog has quoted tirzepatide at $299, $349, and $449 in different posts. It is also a very young company for a long commitment.
4. MEDVi — Low Doses by Shot or Daily Tablet
Delaware-based MEDVi claims over 100,000 patients since 2023, per its own January 2026 press release, and brings a format choice the others mostly lack: compounded semaglutide and tirzepatide as weekly injections or daily dissolvable tablets. For people microdosing to dodge side effects, having a tablet fallback is a real convenience.
Pricing Structure
The core plan is compounded semaglutide injection at $179 the first month, then a flat $299/month — the refill price does not rise with dose, so a low-dose patient pays the same as a maintenance-dose one. Tablets start at $249 the first month, though MEDVi does not publish tablet refill prices (third-party reports cite up to $369). Tirzepatide starts around $349, with refills reported by third parties at $399–$499 depending on dose — the flat-rate promise applies to the semaglutide injection plan. One review site reports billing on a 28-day cycle, meaning about 13 charges per year, not 12.
Pros & Cons
Pros: MEDVi publicly names its compounding pharmacies — Triad Rx, RedRock Pharmacy, and Beaker Pharmacy — which most rivals refuse to do. Trustpilot shows a strong ~4.4/5 across roughly 14,000 reviews, prescribing runs through OpenLoop Health clinicians usually within 24 hours, and there is no membership fee on compounded plans.
Cons: The BBB file is ugly: an F rating with 662 complaints, 100 unanswered, and recurring reports of surprise auto-renewal charges around $399. Refunds are generally unavailable once medication is dispensed, and the $179 promo jumps 67% at month two.
5. Sprout Health — Cheapest Entry, Heaviest Baggage
Encinitas-based Sprout Health advertises compounded semaglutide from $149/month with a written guarantee that your price never rises — explicitly even if your dosage increases. It also sells the only sublingual (under-the-tongue) semaglutide in this ranking, an option some low-dose users prefer. It ranks last anyway, because its short history is crowded with red flags.
Pricing Structure
The homepage lists semaglutide from $149/month, with a 3-month supply promoted at $465 (about $155/month, regular $615). Compounded tirzepatide is promoted from $199/month (regular $349). There is no membership or consultation fee, and Sprout refunds your order if the clinician finds you ineligible. Note that third-party reviews have cited different figures ($199–$299/month) at other times — displayed prices appear promotional and shift over time. Compounded medications do not ship to Arkansas, Kansas, or New Mexico.
Pros & Cons
Pros: The price-lock guarantee is in writing on the official site, delivery typically runs 5–7 business days after prescription, and brand-name Wegovy and Zepbound are available for those who insist on FDA-approved products.
Cons: The FDA sent Sprout Health a warning letter on September 9, 2025 for falsely claiming its compounded GLP-1s were FDA-approved; the site now discloses they are not. BBB rates it F, with 32 of 63 complaints unanswered; Trustpilot sits near 2.2/5 with 84% one-star reviews per July 2026 search records. The company has only existed since January 2025. A price lock is worth little if support never answers.
What Is GLP-1 Microdosing — and Does It Actually Work?
Microdosing means holding your dose below the levels the FDA-approved labels treat as therapeutic targets. Wegovy’s prescribing information starts everyone at 0.25mg per week — described as a starting dose, not a treatment dose — and escalates over about 16 weeks to a 2.4mg maintenance dose. Microdosers deliberately stay near the bottom of that ladder. You can see the full standard schedule in our semaglutide dosage chart.
The honest evidence summary is short. STEP 1 (semaglutide 2.4mg) produced ~14.9% mean weight loss at 68 weeks; SURMOUNT-1 (tirzepatide 5–15mg) produced up to ~20.9% at 72 weeks. There is no comparable randomized trial of staying below those doses for weight loss — the support for microdosing is a mix of clinician experience, patient anecdotes, and provider marketing. A licensed clinician can legally prescribe off-label this way, and lower doses do tend to mean milder nausea. But you are trading proven averages for an experiment of one.
One practical note: GLP-1 microdosing almost always runs on compounded vials, because brand-name pens come in fixed doses. Compounded semaglutide and tirzepatide are not FDA-approved, and the FDA has specifically warned about dosing errors with compounded GLP-1s drawn from multi-dose vials — which is exactly what microdosing involves. Our guide to microdosing GLP-1s covers the risk-benefit tradeoff in depth before you spend anything.
How We Ranked These GLP-1 Microdosing Providers
Every score follows the public 5-factor rubric on our How We Rank page: pricing transparency (30%), total cost (25%), safety and sourcing disclosure (20%), service flexibility (15%), and reputation (10%). For this page we asked one extra question of each provider: can a patient realistically run a clinician-supervised low-dose plan here without being financially punished for it? Noom ranks first because it is the only provider that built a real product around the idea. bmiMD, TrimRx, MEDVi, and Sprout Health rank on flat pricing — when every dose costs the same, staying low costs nothing extra. These are editorial ratings from documented research verified in July 2026; we do not test medications ourselves, and affiliate relationships disclosed on this site do not move scores. Sprout Health stays on the list despite its FDA warning letter because readers search for it — the 6.4/10 score tells you what we think.
What Hidden Costs Come With Microdosing Plans?
The GLP-1 microdosing market has its own pricing trap: paying a premium price for less medication. Noom’s Microdose tier settles at $199/month — more than bmiMD charges for its full-dose plan. Run the month-two math before you commit:
| Provider | Advertised price | What you pay after the promo |
|---|---|---|
| Noom Med | $79 first month | $199/mo, billed ~$597 per 12 weeks |
| bmiMD | $99/mo | Requires $1,188 billed upfront for 12 months |
| TrimRx | $199/mo | Annual commitment; ~$349/mo without it |
| MEDVi | $179 first month | $299/mo, reportedly on a 28-day cycle (~13 charges/year) |
| Sprout Health | $149/mo | Promotional; third parties have cited $199–$299/mo |
Beyond the promo jumps, watch three things. Prepay walls: the lowest advertised prices at bmiMD and TrimRx require 12-month commitments. Cancellation friction: bmiMD charges a $50 fee in its cancellation window and makes pharmacy-processed sales final; TrimRx and Sprout Health complaints center on hard-to-stop subscriptions. Billing cadence: Noom bills quarterly and MEDVi reportedly every 28 days, so the “monthly” price understates the yearly total.
Who Should — and Should Not — Consider Low-Dose GLP-1 Therapy?
The people who plausibly benefit fall into three groups: patients who had rough side effects at standard doses, people seeking modest appetite control rather than maximum loss, and those using a low dose for maintenance after reaching goal weight — the most clinically interesting case, since stopping GLP-1s entirely usually brings regain, as our guide to what happens when you stop GLP-1s explains.
Qualification still matters. Standard telehealth criteria mirror the FDA labels: BMI 30+, or 27+ with a weight-related condition like high blood pressure or sleep apnea. Noom’s Proactive Health microdose program is reportedly open at BMI 21+ per company materials — a much lower bar than the approved labels, and a reason for extra caution, not less. Skip GLP-1s at any dose if you have a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or are pregnant or planning to be. And if a provider will not put a clinician between you and a microdose plan, that is not a program — it is a vial with a subscription attached.